Rhythm Pharmaceuticals buy Morgan Stanley
Start price
16.10.25
/
50%
€95.00
Target price
16.10.26
€110.50
Performance (%)
0.53%
Price
17.12.25
€94.00
Summary
This prediction is currently active. The BUY prediction by Morgan_Stanley for Rhythm Pharmaceuticals is nearly unchanged. This prediction currently runs until 16.10.26. The prediction end date can be changed by Morgan_Stanley at any time. Morgan_Stanley has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Rhythm Pharmaceuticals | 10.588% | 10.588% |
| iShares Core DAX® | -1.212% | 1.925% |
| iShares Nasdaq 100 | -4.714% | -1.810% |
| iShares Nikkei 225® | -2.976% | -2.660% |
| iShares S&P 500 | -2.744% | -0.448% |
Comments by Morgan_Stanley for this prediction
In the thread Rhythm Pharmaceuticals diskutieren
Rhythm Pharmaceuticals (NASDAQ:RYTM) was given a new $129.00 price target on by analysts at Morgan Stanley. They now have an "overweight" rating on the stock.
Ratings data for RYTM provided by MarketBeat
Stopped prediction by Morgan_Stanley for Rhythm Pharmaceuticals
Rhythm Pharmaceuticals
Start price
Target price
Perf. (%)
€100.00
11.12.25
11.12.25
-
11.12.26
11.12.26
-4.50%
17.12.25
17.12.25
Rhythm Pharmaceuticals
Start price
Target price
Perf. (%)
€83.00
25.09.25
25.09.25
-
25.09.26
25.09.26
13.25%
17.12.25
17.12.25
Rhythm Pharmaceuticals
Start price
Target price
Perf. (%)
€74.50
11.07.25
11.07.25
€81.37
11.07.26
11.07.26
28.19%
17.12.25
17.12.25
Rhythm Pharmaceuticals
Start price
Target price
Perf. (%)
€46.80
07.03.25
07.03.25
€66.38
07.03.26
07.03.26
104.06%
17.12.25
17.12.25
Rhythm Pharmaceuticals
Start price
Target price
Perf. (%)
€42.40
19.12.23
19.12.23
€50.16
19.12.24
19.12.24
30.90%
20.12.24
20.12.24